HTR1A and drug-induced dyskinesia: In this regard, several studies have revealed that 5-HT1A receptor agonists could be used prophylactically to reduce L-DOPA-induced dyskinesia by stimulating 5-HT1A inhibitory autoreceptors within the raphe nuclei, which may normalize the amount of DA delivered to the striatum (23).